Evidence map›Paper›PMID 41353755›Full record

ArticleJournal of chemical information and modeling2025

Combining Bayesian and Evidential Uncertainty Quantification for Improved Bioactivity Modeling.

Bola Khalil, Kajetan Schweighofer, Natalia Dyubankova, Gerard J P van Westen, Herman van Vlijmen

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Bridging between Structure-Based and Data-Driven Affinity Prediction.Journal of chemical information and modeling · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bola KhalilComputational Drug Discovery (CDD), Division of Medicinal Chemistry, Leiden University, 2333 CC Leiden, The Netherlands.ORCID 0000-0002-9137-992X
Kajetan SchweighoferELLIS Unit Linz and LIT AI Lab, Institute for Machine Learning, Johannes Kepler University Linz, 4040 Linz, Austria.ORCID 0009-0001-0482-2699
Natalia DyubankovaIn Silico Discovery (ISD), Johnson & Johnson, 2340 Beerse, Belgium.ORCID 0000-0002-5892-3778
Gerard J P van WestenComputational Drug Discovery (CDD), Division of Medicinal Chemistry, Leiden University, 2333 CC Leiden, The Netherlands.ORCID 0000-0003-0717-1817
Herman van VlijmenComputational Drug Discovery (CDD), Division of Medicinal Chemistry, Leiden University, 2333 CC Leiden, The Netherlands.ORCID 0000-0002-1915-3141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uncertainty quantification (UQ) has been recognized as a prerequisite for reliable and trustworthy computational modeling in drug discovery. Two widely considered paradigms, Bayesian methods (deep ensemble and MC dropout) and evidential learning, differ in their computational demands and expressivity of uncertainties, excelling in complementary settings. Here, we propose hybrid approaches that combine both paradigms and benchmark them on the Papyrus++ data set across two end points (

Indexed as

Drug DiscoveryBayes TheoremUncertainty

Identifiers

PMID41353755
PMCPMC12728939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.